Compounds > 2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate
Page last updated: 2024-12-10
2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate
Description
## 2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate: A Powerful Tool for Studying Adenosine Kinase
The compound you've described, **2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate**, is a complex molecule with several important features:
* **Ethenoadenosine:** The core of the molecule is an adenosine derivative with an etheno bridge connecting the N1 and N6 positions. This etheno bridge **increases the fluorescence of the molecule**, making it a useful probe for various biological studies.
* **2',5'-Bisphosphate:** The molecule contains two phosphate groups attached to the 2' and 5' positions of the ribose sugar. This allows the compound to **mimic the natural substrate of adenosine kinase, adenosine monophosphate (AMP).**
* **(4-bromo-2,3-dioxobutyl)thio:** This side chain is critical for the compound's function. It **inhibits the enzyme adenosine kinase** by acting as a **suicide substrate**, meaning it gets incorporated into the enzyme's active site and irreversibly disables it.
**Importance for Research:**
This compound is a **valuable tool for studying adenosine kinase**, a crucial enzyme involved in **purine metabolism and cellular signaling**. It allows researchers to:
* **Inhibit adenosine kinase activity**: The compound can effectively block the enzyme's function, enabling researchers to investigate the consequences of adenosine kinase inhibition in different biological contexts.
* **Investigate adenosine kinase's role in disease**: By studying the effects of adenosine kinase inhibition, researchers can gain insights into its role in various diseases, including cancer, inflammation, and neurological disorders.
* **Develop new drugs targeting adenosine kinase**: Understanding the mechanism of action of this compound can lead to the development of new drugs that specifically target adenosine kinase and potentially offer therapeutic benefits for specific diseases.
* **Track adenosine kinase activity**: The compound's fluorescent properties can be used to track the enzyme's activity in living cells, providing valuable insights into its localization, dynamics, and interactions with other cellular components.
**In summary**, 2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate is a unique and powerful tool that has significantly contributed to our understanding of adenosine kinase, opening new avenues for research and therapeutic development.
2-((4-bromo-2,3-dioxobutyl)thio)-1,N(6)-ethenoadenosine 2',5'-bisphosphate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3035787 |
MeSH ID | M0137335 |
Synonyms (6)
Synonym |
bdb-t-epsilon-adp |
[(2r,3r,4r,5r)-2-[5-(4-bromo-2,3-dioxobutyl)sulfanylimidazo[2,1-f]purin-3-yl]-4-hydroxy-5-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate |
2,3-butanedione, 1-bromo-4-((3-(2,5-di-o-phosphono-beta-d-ribofuranosyl)-3h-imidazo(2,1-i)purin-5-yl)thio)- |
98088-69-8 |
2-((4-bromo-2,3-dioxobutyl)thio)-1,n(6)-ethenoadenosine 2',5'-bisphosphate |
DTXSID00243430 |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.05 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.36 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |